Insider Buying: YD Bio (NASDAQ:YDES) CEO Purchases $12,183.00 in Stock

Posted by Michael Walen on Sep 13th, 2026

YD Bio Limited (NASDAQ:YDES – Get Free Report) CEO Ethan Shen bought 3,100 shares of YD Bio stock in a transaction dated Wednesday, September 9th. The stock was purchased at an average price of $3.93 per share, with a total value of $12,183.00. Following the purchase, the chief executive officer directly owned 11,245,631 shares in the company, valued at approximately $44,195,329.83. This trade represents a 0.03% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available through this link.

YD Bio Stock Up 2.6%

Shares of NASDAQ:YDES opened at $4.00 on Friday. YD Bio Limited has a fifty-two week low of $1.70 and a fifty-two week high of $25.00. The firm’s 50-day simple moving average is $3.02 and its 200-day simple moving average is $4.52.

YD Bio (NASDAQ:YDES – Get Free Report) last posted its quarterly earnings results on Tuesday, September 1st. The biotechnology company reported $0.05 earnings per share (EPS) for the quarter. The firm had revenue of $0.42 million for the quarter.

Institutional Trading of YD Bio

A hedge fund recently raised its stake in YD Bio stock. Cypress Capital Management LLC WY lifted its holdings in YD Bio Limited (NASDAQ:YDES – Free Report) by 9.8% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 33,690 shares of the biotechnology company’s stock after buying an additional 3,000 shares during the quarter. Cypress Capital Management LLC WY’s holdings in YD Bio were worth $76,000 as of its most recent SEC filing.